The actions of insiders often reflect their opinion of where the company is headed. A CFO is unlikely to buy shares of the company if he believes it is in bad shape. While some truly are clueless, here a few which have already demonstrated to an uncanny ability to time their stock buys. The Daily Insider, which uses SEC insider transaction data to recommend 4 stocks with the best upside potential. recommended these 4 stocks on March 16, 2016. Let’s take a closer look at some insider transactions for Huntington Bancshares Incorporated (NASDAQ: HBAN), OvaScience, Inc. (NASDAQ: OVAS), Flex Pharma, Inc. (NASDAQ: FLKS) Amplify Snack Brands, Inc. (NYSE: BETR). The first insider is Stephen Steinour, CEO of Huntington Bancshares Incorporated , who bought up half a million worth of shares on March 15, 2016. On the same date one of the company’s directors, John Gerlach, also bought $100,000 worth of shares. According to financial engine TipRanks, both insiders are highly ranked, with 4 and 5 stars respectively.
Huntington Bancshares, Inc. is an American bank holding company headquartered in Columbus, Ohio. It currently trades at $9.48, at around the same level as when the insiders made their transactions. If the market does not retract and history repeats itself, this stock has a high probability of taking off.
Our second pick, OvaScience, is already up 75% for the month, but it was a transaction by CEO Michelle Dipp who triggered us to notice it. OvaScience develops, and commercializes new fertility treatment options for women worldwide. Accompanying his huge insider transaction of $1.2m was the company director Richard Aldrich, who purchased shares for the same amount.
Since making their initial purchase the two have been buying up massive amounts of stock. We detected the upside potential on March 16, 2016, while the stock was trading at just $7.73. Since then the price shot up to $9.76, representing a 30% increase. Their continued purchasing suggests there is still some upside for investors looking to join the party late.
Another stock which captured our attention is Flex Pharma, Inc., which at the time had 4 insiders buy the stock (when?). CEO Chrisoph Westphal, has a very consistent history of insider buying in the company. According to TipRanks, Westphal has an average return of 19% on his transactions. His biggest insider buy was a purchase of OVAS stock two years ago which earned him 350% and as a result was obliged to report the OVAS transaction as a director and 10% owner; however his CEO position makes this that much more informative. The stock is up 2% since he made his initial purchase on March 16.
Finally, already up 7.5% since being recommended by the Daily Insider is Amplify Snack Brands, Inc. (NYSE: BETR). The lesser known brand had CEO Ennis Thomas, CFO Goldberg Brian, and SVP Shiver Jason all purchase up company shares on the same day (which day?). While all three do not have a historical track record due to their low number of transactions, their key positions indicate this stock is likely to skyrocket soon.
These four stocks were all recommended on the March 16, 2016 issue of the DailyInsider downloadable here. To learn more from how you can profit based on the actions of insiders and subscribe to our newsletter visit our information center here.